Jiangsu Hengrui Medicine
600276.SS
#488
Rank
$42.07 B
Marketcap
$6.60
Share price
-1.55%
Change (1 day)
2.27%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Total assets

Total assets on the balance sheet as of September 2024 : $6.89 Billion USD

According to Jiangsu Hengrui Medicine 's latest financial reports the company's total assets are $6.89 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Jiangsu Hengrui Medicine - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2022-12-31$6.14 B-0.34%
2021-12-31$6.16 B15.73%
2020-12-31$5.32 B34.99%
2019-12-31$3.94 B20.51%
2018-12-31$3.27 B18.05%
2017-12-31$2.77 B34.36%
2016-12-31$2.06 B16.34%
2015-12-31$1.77 B20.87%
2014-12-31$1.46 B23%
2013-12-31$1.19 B26.24%
2012-12-31$0.94 B23.29%
2011-12-31$0.76 B30.12%
2010-12-31$0.58 B34.19%
2009-12-31$0.43 B32.69%
2008-12-31$0.33 B17.28%
2007-12-31$0.28 B49.97%
2006-12-31$0.18 B18.09%
2005-12-31$0.15 B4.89%
2004-12-31$0.15 B-13.46%
2003-12-31$0.17 B20.58%
2002-12-31$0.14 B7.64%
2001-12-31$0.13 B